NeoMed Innovation IV closed at EUR 104 million
NeoMed Innovation IV LP closed at EUR 104 million. The investors are fund-of-funds, institutional and private investors situated in Europe and Saudi Arabia.
NeoMed is one of Europe’s leading venture capital firms which specialises in healthcare and life sciences. It invests in innovative and emerging companies, primarily in Continental Europe and Scandinavia.
The new fund recently made its first investment in the Swiss company Endosense SA.
Read more